Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 4
1(14.3%)
7Total
N/A(6)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT03884049Not ApplicableCompleted

Neovascularization Embolisation for Knee Osteoarthritis.(NEO)

Role: collaborator

NCT00526487Not ApplicableCompleted

Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection

Role: lead

NCT00470626Not ApplicableCompleted

Celect Vena Cava Filter Clinical Trial

Role: collaborator

NCT00118573Phase 4Terminated

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

Role: collaborator

NCT00111176Not ApplicableCompleted

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Role: collaborator

NCT00120406Not ApplicableCompleted

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Role: collaborator

NCT01728441Not ApplicableCompleted

Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

Role: collaborator

NCT01788904Unknown

Plasma i-FABP as Predictor for Irreversible Bowel Ischemia

Role: collaborator

All 8 trials loaded